Marylou V. Solbrig

2.3k total citations
33 papers, 767 citations indexed

About

Marylou V. Solbrig is a scholar working on Epidemiology, Infectious Diseases and Cellular and Molecular Neuroscience. According to data from OpenAlex, Marylou V. Solbrig has authored 33 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 16 papers in Infectious Diseases and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Marylou V. Solbrig's work include Virology and Viral Diseases (14 papers), Infectious Encephalopathies and Encephalitis (11 papers) and Neuroscience and Neuropharmacology Research (8 papers). Marylou V. Solbrig is often cited by papers focused on Virology and Viral Diseases (14 papers), Infectious Encephalopathies and Encephalitis (11 papers) and Neuroscience and Neuropharmacology Research (8 papers). Marylou V. Solbrig collaborates with scholars based in United States, Canada and Italy. Marylou V. Solbrig's co-authors include W. Ian Lipkin, George F. Koob, James H. Fallon, Guey‐Chuen Perng, Nigel Horscroft, Herbert Weißenböck, Mady Hornig, Marco Bortolato, Janie Baratta and Neal Hermanowicz and has published in prestigious journals such as Journal of Neuroscience, Brain and Neurology.

In The Last Decade

Marylou V. Solbrig

33 papers receiving 742 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marylou V. Solbrig United States 20 304 199 192 130 128 33 767
Mark J. Harding United States 16 287 0.9× 72 0.4× 357 1.9× 53 0.4× 56 0.4× 37 1.0k
Rosario Leopardi Sweden 18 563 1.9× 72 0.4× 112 0.6× 64 0.5× 34 0.3× 22 1.1k
P Satishchandra India 21 253 0.8× 296 1.5× 244 1.3× 180 1.4× 144 1.1× 46 1.2k
James B. Stanton United States 16 245 0.8× 144 0.7× 153 0.8× 23 0.2× 46 0.4× 61 1.1k
H. Friedman United States 16 127 0.4× 143 0.7× 73 0.4× 150 1.2× 54 0.4× 37 955
Saman Nematollahi United States 18 321 1.1× 312 1.6× 251 1.3× 171 1.3× 96 0.8× 51 1.2k
Lisa Lott United States 18 358 1.2× 218 1.1× 136 0.7× 12 0.1× 60 0.5× 34 878
Diane M. Lawrence United States 21 237 0.8× 237 1.2× 127 0.7× 224 1.7× 71 0.6× 32 1.2k
Molly E. Eaton United States 16 238 0.8× 251 1.3× 416 2.2× 60 0.5× 131 1.0× 22 1.7k
Kathleen A. Williams Germany 13 205 0.7× 184 0.9× 63 0.3× 65 0.5× 86 0.7× 27 955

Countries citing papers authored by Marylou V. Solbrig

Since Specialization
Citations

This map shows the geographic impact of Marylou V. Solbrig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marylou V. Solbrig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marylou V. Solbrig more than expected).

Fields of papers citing papers by Marylou V. Solbrig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marylou V. Solbrig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marylou V. Solbrig. The network helps show where Marylou V. Solbrig may publish in the future.

Co-authorship network of co-authors of Marylou V. Solbrig

This figure shows the co-authorship network connecting the top 25 collaborators of Marylou V. Solbrig. A scholar is included among the top collaborators of Marylou V. Solbrig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marylou V. Solbrig. Marylou V. Solbrig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Solbrig, Marylou V. & Guey‐Chuen Perng. (2015). Current Neurological Observations and Complications of Dengue Virus Infection. Current Neurology and Neuroscience Reports. 15(6). 29–29. 29 indexed citations
2.
Bortolato, Marco, Valentina Bini, Roberto Frau, et al.. (2014). Juvenile cannabinoid treatment induces frontostriatal gliogenesis in Lewis rats. European Neuropsychopharmacology. 24(6). 974–985. 23 indexed citations
3.
Jay, Cheryl A. & Marylou V. Solbrig. (2014). Neurologic infections in diabetes mellitus. Handbook of clinical neurology. 126. 175–194. 3 indexed citations
4.
Solbrig, Marylou V., Yijun Fan, & Paul R. Hazelton. (2013). Prospects for cannabinoid therapies in viral encephalitis. Brain Research. 1537. 273–282. 6 indexed citations
5.
Solbrig, Marylou V. & Guey‐Chuen Perng. (2010). Role of Infection in Neurologic and Psychiatric Diseases. Interdisciplinary Perspectives on Infectious Diseases. 2010. 1–1. 2 indexed citations
6.
Solbrig, Marylou V., Yijun Fan, Neal Hermanowicz, Maria Grazia Morgese, & Andrea Giuffrida. (2010). A synthetic cannabinoid agonist promotes oligodendrogliogenesis during viral encephalitis in rats. Experimental Neurology. 226(1). 231–241. 29 indexed citations
7.
Solbrig, Marylou V. & Neal Hermanowicz. (2008). Cannabinoid rescue of striatal progenitor cells in chronic Borna Disease viral encephalitis in rats. Journal of NeuroVirology. 14(3). 252–260. 12 indexed citations
8.
Bortolato, Marco & Marylou V. Solbrig. (2007). The price of seizure control: Dynorphins in interictal and postictal psychosis. Psychiatry Research. 151(1-2). 139–143. 19 indexed citations
9.
Glaser, Carol, Sabrina Gilliam, Somayeh Honarmand, et al.. (2007). Refractory Status Epilepticus in Suspect Encephalitis. Neurocritical Care. 9(1). 74–82. 28 indexed citations
10.
Solbrig, Marylou V., et al.. (2006). Kappa opioid control of seizures produced by a virus in an animal model. Brain. 129(3). 642–654. 44 indexed citations
11.
Solbrig, Marylou V., et al.. (2005). A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Experimental Neurology. 194(2). 355–362. 21 indexed citations
12.
Nash, Justin M., Bradley N. Collins, Sandra E. Loughlin, et al.. (2003). Training the transdisciplinary scientist: A general framework applied to tobacco use behavior. Nicotine & Tobacco Research. 5(6). 41–53. 49 indexed citations
13.
Solbrig, Marylou V. & George F. Koob. (2003). Neuropharmacological sequelae of persistent CNS viral infections: lessons from Borna Disease Virus. Pharmacology Biochemistry and Behavior. 74(4). 777–787. 12 indexed citations
14.
Hornig, Mady, Marylou V. Solbrig, Nigel Horscroft, Herbert Weißenböck, & W. Ian Lipkin. (2001). Borna Disease Virus Infection of Adult and Neonatal Rats: Models for Neuropsychiatric Disease. Current topics in microbiology and immunology. 253. 157–177. 70 indexed citations
15.
Solbrig, Marylou V., George F. Koob, & W. Ian Lipkin. (1999). Orofacial dyskinesias and dystonia in rats infected with Borna disease virus; a model for tardive dyskinetic syndromes. Molecular Psychiatry. 4(4). 310–312. 4 indexed citations
16.
Solbrig, Marylou V., George F. Koob, & W. Ian Lipkin. (1998). Cocaine Sensitivity in Borna Disease Virus-Infected Rats. Pharmacology Biochemistry and Behavior. 59(4). 1047–1052. 17 indexed citations
17.
Solbrig, Marylou V., George F. Koob, Jeffrey N. Joyce, & W. Ian Lipkin. (1996). A Neural Substrate of Hyperactivity in Borna Disease: Changes in Brain Dopamine Receptors. Virology. 222(2). 332–338. 41 indexed citations
18.
Solbrig, Marylou V., James H. Fallon, & W. Ian Lipkin. (1995). Behavioral Disturbances and Pharmacology of Borna Disease. Current topics in microbiology and immunology. 190. 93–101. 41 indexed citations
19.
Schneemann, Anette, et al.. (1995). Borna disease virus: implications for human neuropsychiatric illness. Trends in Microbiology. 3(2). 64–69. 36 indexed citations
20.
Solbrig, Marylou V. & Lina Nashef. (1993). Acute parkinsonism in suspected herpes simplex encephalitis. Movement Disorders. 8(2). 233–234. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark J. Harding Breakdown of academic impact, for papers by Rosario Leopardi Breakdown of academic impact, for papers by P Satishchandra Breakdown of academic impact, for papers by James B. Stanton Breakdown of academic impact, for papers by H. Friedman Breakdown of academic impact, for papers by Saman Nematollahi Breakdown of academic impact, for papers by Lisa Lott Breakdown of academic impact, for papers by Diane M. Lawrence Breakdown of academic impact, for papers by Molly E. Eaton Breakdown of academic impact, for papers by Kathleen A. Williams
Rankless by CCL
2026